Executive Director, Global Medical Affairs Strategy

Full Time On-Site/Hybrid Medical Affairs Director GMA Strategy Apply for this Job The Executive Director, Global Medical Affairs (GMA) Strategy, is a key member of the GMA team who will lead a cross therapeutic area and cross functional Medical Affairs team at the global level. Reporting into the Exec. Director, GMA Strategy will be the lead for Rare Disease, lead for Ophthalmology, and the Advocacy lead. This individual will work closely with medical affairs, clinical operations, clinical development, commercial, legal, regulatory, quality, research, and corporate communications to oversee the GMA strategy and execution on both rare disease and ophthalmology programs. Additionally, the Executive Director, GMA Strategy Lead, will ensure close collaboration at the regional, country, and alliance level by providing effective leadership, strategic insight, and ensuring execution of key initiatives to enable successful preparation and launch of the all therapeutic area programs.

Key Responsibilities Include:

• Key member of the Medical Affairs Leadership Team
• Lead Global Medical Affairs (GMA) Medical Directors, Scientific communications, and Advocacy efforts across indications
• Oversee development and implementation of GMA strategy for pegcetacoplan across hematology, nephrology, and ophthalmology
• Ensure appropriate representation of late-stage development programs at the respective program teams
• Oversee collaborative alliance partnership with partner company
• Collaborate with systemic leads across Clinical Development, Regulatory, Commercial, Development Operations and other functions as needed to ensure appropriate strategic alignment, prioritization, and execution of systemic and intravitreal pegcetacoplan strategy and plans
• Responsible for line management, professional development, and mentorship of direct report(s) including providing feedback on employee performance and goal setting
• Responsible for driving strategic initiatives for employee development, process, and business improvements
• Fosters and reinforces a culture that aligns with the Apellis Values
• Up to 40% domestic and/or international travel
• Other duties and responsibilities as required

Education, Registration & Certification:

• Must have a PhD, Pharm D or MD level degree or equivalent

Experience:

• 18+ years of experience in a Medical Affairs organization
• Experience in ophthalmology, hematology, or nephrology strongly preferred
• Significant experience across drug life cycle, particularly in phase 3 development and post-marketing setting
• Exhibits strong global mindset
• Alliance management experience preferred

Skills, Knowledge & Abilities:

• Proven ability to lead in a fast-paced environment, enabling the team to prioritize and manage multiple competing tasks and demands while ensuring overall quality and integrity
• Enables creative problem solving, encourages unique solutions, and solves difficult problems with effective solutions
• Creates an environment that enables open, available, and transparent communication
• Strong interpersonal skill set necessary to influence and maintain internal effective and external collaborator relationships
• Facilitates productive dialogue that empowers others to share input/recommendations/perspective, while driving the group to make a decision or take a position.
• Highly developed written and verbal communication skills, including ability to effectively articulate highly technical/complex concepts to audiences with differing levels of experience
• Demonstrated ability to effectively lead, influence, and manage within a matrixed organization
• Exceptional leadership skills and ability to inspire, motivate and mentor teams

Benefits and Perks:

Apellis offers a great benefit package which includes: health insurance with full premium coverage, 401K with company match, paid time off (PTO), long- term disability insurance, life insurance and more! Visit https://apellis.com/careers/ to learn more.

Company Background:

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first and only therapy for geographic atrophy, a leading cause of blindness around the world. With nearly a dozen clinical and pre-clinical programs underway, we believe we have only begun to unlock the potential of targeting C3 across many serious diseases.